{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T16:19:37Z","timestamp":1789402777335,"version":"build-2803163510"},"reference-count":188,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Cell & Developmental Biology"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1016\/j.semcdb.2021.04.001","type":"journal-article","created":{"date-parts":[[2021,4,16]],"date-time":"2021-04-16T06:08:05Z","timestamp":1618553285000},"page":"99-113","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["The emerging role of miRNA in the perturbation of tumor immune microenvironment in chemoresistance: Therapeutic implications"],"prefix":"10.1016","volume":"124","author":[{"given":"Priya","family":"Mondal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhavjot","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jagadish","family":"Natesh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syed Musthapa","family":"Meeran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.semcdb.2021.04.001_bib1","first-page":"1","article-title":"Role of microRNAs in chemoresistance","volume":"3","author":"Magee","year":"2015","journal-title":"Ann. Transl. Med."},{"key":"10.1016\/j.semcdb.2021.04.001_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fonc.2020.603661","article-title":"The role of autophagy in tumor immunology\u2014complex mechanisms that may be explored therapeutically","volume":"10","author":"de Souza","year":"2020","journal-title":"Front. Oncol."},{"key":"10.1016\/j.semcdb.2021.04.001_bib3","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1007\/s00262-012-1231-7","article-title":"Tumor-infiltrating lymphocytes predict response to chemotherapy in patients with advance non-small cell lung cancer","volume":"61","author":"Liu","year":"2012","journal-title":"Cancer Immunol. Immunother."},{"issue":"3","key":"10.1016\/j.semcdb.2021.04.001_bib4","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1002\/ijc.25619","article-title":"Tumor associated mesenchymal stem cells protects ovarian cancer cells from hyperthermia through CXCL12","volume":"128","author":"Lis","year":"2011","journal-title":"Int. J. Cancer"},{"issue":"9","key":"10.1016\/j.semcdb.2021.04.001_bib5","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/nrc2714","article-title":"Environment-mediated drug resistance: a major contributor to minimal residual disease","volume":"9","author":"Meads","year":"2009","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.semcdb.2021.04.001_bib6","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1101\/gad.180331.111","article-title":"Macrophages and cathepsin proteases blunt chemotherapeutic response in breast cancer","volume":"25","author":"Shree","year":"2011","journal-title":"Genes Dev."},{"issue":"3","key":"10.1016\/j.semcdb.2021.04.001_bib7","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.drup.2011.03.001","article-title":"Hypoxia-mediated drug resistance: Novel insights on the functional interaction of HIFs and cell death pathways","volume":"14","author":"Rohwer","year":"2011","journal-title":"Drug Resist. Updat."},{"issue":"9","key":"10.1016\/j.semcdb.2021.04.001_bib8","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1038\/s41423-020-0505-9","article-title":"Epigenetics in modulating immune functions of stromal and immune cells in the tumor microenvironment","volume":"17","author":"Pan","year":"2020","journal-title":"Cell. Mol. Immunol."},{"issue":"13","key":"10.1016\/j.semcdb.2021.04.001_bib9","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.2174\/1389200221666200106105201","article-title":"Non-coding RNAs in lung cancer chemoresistance","volume":"20","author":"Mondal","year":"2020","journal-title":"Curr. Drug Metab."},{"issue":"4","key":"10.1016\/j.semcdb.2021.04.001_bib10","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.ncrna.2020.11.004","article-title":"Long non-coding RNAs in breast cancer metastasis","volume":"5","author":"Mondal","year":"2020","journal-title":"Non Coding RNA Res."},{"key":"10.1016\/j.semcdb.2021.04.001_bib11","series-title":"Cancer Drug Resist","first-page":"377","article-title":"De Novo and Acquired Resistance to Antitumor Alkylating Agents","author":"Hazlehurst","year":"2007"},{"issue":"1\u20132","key":"10.1016\/j.semcdb.2021.04.001_bib12","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s10555-012-9415-3","article-title":"Stromal cells in tumor microenvironment and breast cancer","volume":"32","author":"Mao","year":"2013","journal-title":"Cancer Metastas Rev."},{"issue":"2","key":"10.1016\/j.semcdb.2021.04.001_bib13","doi-asserted-by":"crossref","first-page":"253","DOI":"10.4252\/wjsc.v7.i2.253","article-title":"Hematopoietic stem cell-derived adipocytes and fibroblasts in the tumor microenvironment","volume":"7","author":"Xiong","year":"2015","journal-title":"World J. Stem Cells"},{"issue":"2","key":"10.1016\/j.semcdb.2021.04.001_bib14","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.lungcan.2013.08.008","article-title":"Interaction between non-small-cell lung cancer cells and fibroblasts via enhancement of TGF-\u03b2 signaling by IL-6","volume":"82","author":"Abulaiti","year":"2013","journal-title":"Lung Cancer"},{"issue":"23","key":"10.1016\/j.semcdb.2021.04.001_bib15","doi-asserted-by":"crossref","first-page":"5301","DOI":"10.3748\/wjg.v22.i23.5301","article-title":"Fibroblasts, an inconspicuous but essential player in colon cancer development and progression","volume":"22","author":"Mukaida","year":"2016","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.semcdb.2021.04.001_bib16","first-page":"8851","article-title":"Autocrine production of interleukin 6 causes multidrug resistance in breast cancer cells","volume":"61","author":"Conze","year":"2001","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.semcdb.2021.04.001_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/srep38408","article-title":"Cancer-associated fibroblasts treated with cisplatin facilitates chemoresistance of lung adenocarcinoma through IL-11\/IL-11R\/STAT3 signaling pathway","volume":"6","author":"Tao","year":"2016","journal-title":"Sci. Rep."},{"issue":"8","key":"10.1016\/j.semcdb.2021.04.001_bib18","doi-asserted-by":"crossref","first-page":"4499","DOI":"10.4049\/jimmunol.0802740","article-title":"Myeloid-derived suppressor cells: linking inflammation and cancer","volume":"182","author":"Ostrand-Rosenberg","year":"2009","journal-title":"J. Immunol."},{"issue":"7","key":"10.1016\/j.semcdb.2021.04.001_bib19","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.3390\/ijms18071586","article-title":"The role of tumor microenvironment in chemoresistance: To survive, keep your enemies closer","volume":"18","author":"Senthebane","year":"2017","journal-title":"Int. J. Mol. Sci."},{"issue":"12","key":"10.1016\/j.semcdb.2021.04.001_bib20","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1038\/nri2448","article-title":"Exploring the full spectrum of macrophage activation","volume":"8","author":"Mosser","year":"2008","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.semcdb.2021.04.001_bib21","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.semcancer.2008.03.004","article-title":"Macrophage polarization in tumour progression","volume":"18","author":"Sica","year":"2008","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.semcdb.2021.04.001_bib22","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.lungcan.2019.08.023","article-title":"PD-L1 expression on tumor-infiltrating immune cells is highly associated with M2 TAM and aggressive malignant potential in patients with resected non-small cell lung cancer","volume":"136","author":"Sumitomo","year":"2019","journal-title":"Lung Cancer"},{"key":"10.1016\/j.semcdb.2021.04.001_bib23","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.ccell.2015.02.015","article-title":"Macrophages and therapeutic resistance in cancer","volume":"27","author":"Ruffell","year":"2015","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1016\/j.semcdb.2021.04.001_bib24","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.canlet.2016.02.048","article-title":"Cancer development, chemoresistance, epithelial to mesenchymal transition and stem cells: a snapshot of IL-6 mediated involvement","volume":"375","author":"Bharti","year":"2016","journal-title":"Cancer Lett."},{"issue":"1","key":"10.1016\/j.semcdb.2021.04.001_bib25","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/nm976","article-title":"Regulation of the innate and adaptive immune responses by Stat-3 signaling in tumor cells","volume":"10","author":"Wang","year":"2004","journal-title":"Nat. Med."},{"issue":"7","key":"10.1016\/j.semcdb.2021.04.001_bib26","doi-asserted-by":"crossref","first-page":"3925","DOI":"10.4049\/jimmunol.174.7.3925","article-title":"Stat3 Activity in melanoma cells affects migration of immune effector cells and nitric oxide-mediated antitumor effects","volume":"174","author":"Burdelya","year":"2005","journal-title":"J. Immunol."},{"issue":"2","key":"10.1016\/j.semcdb.2021.04.001_bib27","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1172\/JCI59227","article-title":"Oncogenic Kras is required for both the initiation and maintenance of pancreatic cancer in mice","volume":"122","author":"Collins","year":"2012","journal-title":"J. Clin. Invest."},{"issue":"5","key":"10.1016\/j.semcdb.2021.04.001_bib28","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.ccr.2014.03.033","article-title":"Loss of lkb1 and pten leads to lung squamous cell carcinoma with elevated pd-l1 expression","volume":"25","author":"Xu","year":"2014","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1016\/j.semcdb.2021.04.001_bib29","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1038\/nm1517","article-title":"Loss of tumor suppressor PTEN function increases B7-H1 expression and immunoresistance in glioma","volume":"13","author":"Parsa","year":"2007","journal-title":"Nat. Med."},{"key":"10.1016\/j.semcdb.2021.04.001_bib30","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/43474","article-title":"NF-\u03baB is a target of AKT in anti-apoptotic PDGF signalling","volume":"401","author":"Romashkova","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.semcdb.2021.04.001_bib31","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/1476-4598-12-86","article-title":"The complexity of NF-\u03baB signaling in inflammation and cancer","volume":"12","author":"Hoesel","year":"2013","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.semcdb.2021.04.001_bib32","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1471-2407-10-163","article-title":"Expression of tumor-specific antigen MAGE, GAGE and BAGE in ovarian cancer tissues and cell lines","volume":"10","author":"Zhang","year":"2010","journal-title":"BMC Cancer"},{"key":"10.1016\/j.semcdb.2021.04.001_bib33","doi-asserted-by":"crossref","first-page":"2957","DOI":"10.4049\/jimmunol.1100038","article-title":"Inhibitory receptors on lymphocytes: insights from infections","volume":"188","author":"Odorizzi","year":"2012","journal-title":"J. Immunol."},{"issue":"4","key":"10.1016\/j.semcdb.2021.04.001_bib34","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/nrc3239","article-title":"The blockade of immune checkpoints in cancer immunotherapy","volume":"12","author":"Pardoll","year":"2012","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.semcdb.2021.04.001_bib35","doi-asserted-by":"crossref","first-page":"11406","DOI":"10.1038\/ncomms11406","article-title":"miR-424(322) reverses chemoresistance via T-cell immune response activation by blocking the PD-L1 immune checkpoint","volume":"7","author":"Xu","year":"2016","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.semcdb.2021.04.001_bib36","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1159\/000491909","article-title":"MiR-195\/-16 family enhances radiotherapy via T cell activation in the tumor microenvironment by blocking the PD-L1 immune checkpoint","volume":"48","author":"Tao","year":"2018","journal-title":"Cell. Physiol. Biochem."},{"issue":"1","key":"10.1016\/j.semcdb.2021.04.001_bib37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/imm.12367","article-title":"Immuno-miRs: critical regulators of T-cell development, function and ageing","volume":"144","author":"Kroesen","year":"2015","journal-title":"Immunology"},{"issue":"4","key":"10.1016\/j.semcdb.2021.04.001_bib38","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.immuni.2012.12.006","article-title":"MicroRNA-155 is required for effector cd8+ t cell responses to virus infection and cancer","volume":"38","author":"Dudda","year":"2013","journal-title":"Immunity"},{"issue":"6","key":"10.1016\/j.semcdb.2021.04.001_bib39","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/ni.2576","article-title":"The microRNA miR-155 controls CD8+ T cell responses by regulating interferon signaling","volume":"14","author":"Gracias","year":"2013","journal-title":"Nat. Immunol."},{"issue":"9","key":"10.1016\/j.semcdb.2021.04.001_bib40","doi-asserted-by":"crossref","first-page":"967","DOI":"10.2217\/imt.15.65","article-title":"Strategies for combining immunotherapy with radiation for anticancer therapy","volume":"7","author":"Seyedin","year":"2015","journal-title":"Immunotherapy"},{"issue":"1","key":"10.1016\/j.semcdb.2021.04.001_bib41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jnci\/djv303","article-title":"PDL1 regulation by p53 via miR-34","volume":"108","author":"Cortez","year":"2016","journal-title":"J. Natl. Cancer Inst."},{"issue":"3","key":"10.1016\/j.semcdb.2021.04.001_bib42","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.cellsig.2014.12.003","article-title":"Tumor suppressor miR-34a targets PD-L1 and functions as a potential immunotherapeutic target in acute myeloid leukemia","volume":"27","author":"Wang","year":"2015","journal-title":"Cell. Signal."},{"key":"10.1016\/j.semcdb.2021.04.001_bib43","doi-asserted-by":"crossref","first-page":"5241","DOI":"10.1038\/ncomms6241","article-title":"Metastasis is regulated via microRNA-200\/ZEB1 axis control of tumour cell PD-L1 expression and intratumoral immunosuppression","volume":"5","author":"Chen","year":"2014","journal-title":"Nat. Commun."},{"issue":"50","key":"10.1016\/j.semcdb.2021.04.001_bib44","doi-asserted-by":"crossref","first-page":"20683","DOI":"10.1074\/jbc.M117.809053","article-title":"MicroRNA-155 induction via TNF-\u03b1 and IFN-\u03b3 suppresses expression of programmed death ligand-1 (PD-L1) in human primary cells","volume":"292","author":"Yee","year":"2017","journal-title":"J. Biol. Chem."},{"issue":"6","key":"10.1016\/j.semcdb.2021.04.001_bib45","first-page":"252","article-title":"MiR-570 inhibits proliferation, angiogenesis, and immune escape of hepatocellular carcinoma","volume":"33","author":"Lin","year":"2018","journal-title":"Cancer Biother. Radiopharm."},{"issue":"23","key":"10.1016\/j.semcdb.2021.04.001_bib46","doi-asserted-by":"crossref","first-page":"3151","DOI":"10.1038\/s41388-018-0178-3","article-title":"MiR-21 depletion in macrophages promotes tumoricidal polarization and enhances PD-1 immunotherapy","volume":"37","author":"Xi","year":"2018","journal-title":"Oncogene"},{"issue":"11","key":"10.1016\/j.semcdb.2021.04.001_bib47","doi-asserted-by":"crossref","first-page":"9049","DOI":"10.1007\/s13277-015-3644-3","article-title":"MiR-570 inhibited the cell proliferation and invasion through directly targeting B7-H1 in hepatocellular carcinoma","volume":"36","author":"Guo","year":"2015","journal-title":"Tumor Biol."},{"issue":"3","key":"10.1016\/j.semcdb.2021.04.001_bib48","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s00109-004-0617-1","article-title":"The balance of immune responses: Costimulation verse coinhibition","volume":"83","author":"Subudhi","year":"2005","journal-title":"J. Mol. Med."},{"key":"10.1016\/j.semcdb.2021.04.001_bib49","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1186\/s12935-017-0474-y","article-title":"Role of microRNA-33a in regulating the expression of PD-1 in lung adenocarcinoma","volume":"17","author":"Boldrini","year":"2017","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.semcdb.2021.04.001_bib50","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.ebiom.2019.02.034","article-title":"MiR-873\/PD-L1 axis regulates the stemness of breast cancer cells","volume":"41","author":"Gao","year":"2019","journal-title":"EBioMedicine"},{"issue":"10","key":"10.1016\/j.semcdb.2021.04.001_bib51","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1002\/ijc.30912","article-title":"MiR-15a\/16 deficiency enhances anti-tumor immunity of glioma-infiltrating CD8+ T cells through targeting mTOR","volume":"141","author":"Yang","year":"2017","journal-title":"Int. J. Cancer"},{"issue":"33","key":"10.1016\/j.semcdb.2021.04.001_bib52","doi-asserted-by":"crossref","first-page":"53735","DOI":"10.18632\/oncotarget.10731","article-title":"miR-28 modulates exhaustive differentiation of T cells through silencing programmed cell death-1 and regulating cytokine secretion","volume":"7","author":"Li","year":"2016","journal-title":"Oncotarget"},{"issue":"6","key":"10.1016\/j.semcdb.2021.04.001_bib53","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1515\/cclm-2017-0430","article-title":"High microRNA-28-5p expression in colorectal adenocarcinoma predicts short-term relapse of node-negative patients and poor overall survival of patients with non-metastatic disease","volume":"56","author":"Tsiakanikas","year":"2018","journal-title":"Clin. Chem. Lab. Med."},{"issue":"8","key":"10.1016\/j.semcdb.2021.04.001_bib54","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1038\/ni.2057","article-title":"Distinct microRNA signatures in human lymphocyte subsets and enforcement of the naive state in CD4+ T cells by the microRNA miR-125b","volume":"12","author":"Rossi","year":"2011","journal-title":"Nat. Immunol."},{"issue":"23","key":"10.1016\/j.semcdb.2021.04.001_bib55","doi-asserted-by":"crossref","first-page":"3650","DOI":"10.4161\/cc.26585","article-title":"miR-29b induces SOCS-1 expression by promoter demethylation and negatively regulates migration of multiple myeloma and endothelial cells","volume":"12","author":"Amodio","year":"2013","journal-title":"Cell Cycle"},{"issue":"4","key":"10.1016\/j.semcdb.2021.04.001_bib56","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.4049\/jimmunol.1103171","article-title":"miR-29ab1 deficiency identifies a negative feedback loop controlling Th1 bias that is dysregulated in multiple sclerosis","volume":"189","author":"Smith","year":"2012","journal-title":"J. Immunol."},{"key":"10.1016\/j.semcdb.2021.04.001_bib57","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.4049\/jimmunol.1800230","article-title":"miR-143 regulates memory T cell differentiation by reprogramming T cell metabolism","volume":"201","author":"Zhang","year":"2018","journal-title":"J. Immunol."},{"issue":"10","key":"10.1016\/j.semcdb.2021.04.001_bib58","doi-asserted-by":"crossref","DOI":"10.1098\/rsob.190061","article-title":"miR-149-3p reverses CD8+ T-cell exhaustion by reducing inhibitory receptors and promoting cytokine secretion in breast cancer cells","volume":"9","author":"Zhang","year":"2019","journal-title":"Open Biol."},{"issue":"22","key":"10.1016\/j.semcdb.2021.04.001_bib59","doi-asserted-by":"crossref","first-page":"4473","DOI":"10.1182\/blood-2012-06-435412","article-title":"MicroRNA-17~92 regulates effector and memory CD8 T-cell fates by modulating proliferation in response to infections","volume":"121","author":"Khan","year":"2013","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.semcdb.2021.04.001_bib60","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.humimm.2014.01.006","article-title":"MiR-20b, -21, and -130b inhibit PTEN expression resulting in B7-H1 over-expression in advanced colorectal cancer","volume":"75","author":"Zhu","year":"2014","journal-title":"Hum. Immunol."},{"issue":"20","key":"10.1016\/j.semcdb.2021.04.001_bib61","doi-asserted-by":"crossref","first-page":"5487","DOI":"10.1182\/blood-2011-05-355644","article-title":"Molecular dissection of the miR-17-92 cluster\u2019s critical dual roles in promoting Th1 responses and preventing inducible Treg differentiation","volume":"118","author":"Jiang","year":"2011","journal-title":"Blood"},{"issue":"18","key":"10.1016\/j.semcdb.2021.04.001_bib62","doi-asserted-by":"crossref","first-page":"12446","DOI":"10.1074\/jbc.M114.550723","article-title":"Mir-17-92 cluster targets phosphatase and tensin homology and ikaros family zinc finger 4 to promote th17-mediated inflammation","volume":"289","author":"Liu","year":"2014","journal-title":"J. Biol. Chem."},{"issue":"12","key":"10.1016\/j.semcdb.2021.04.001_bib63","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1038\/ni.3026","article-title":"A microRNA upregulated in asthma airway T cells promotes TH2 cytokine production","volume":"15","author":"Simpson","year":"2014","journal-title":"Nat. Immunol."},{"issue":"6","key":"10.1016\/j.semcdb.2021.04.001_bib64","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1158\/2326-6066.CIR-18-0504","article-title":"MicroRNA-155 expression is enhanced by T-cell receptor stimulation strength and correlates with improved tumor control in Melanoma","volume":"7","author":"Martinez-Usatorre","year":"2019","journal-title":"Cancer Immunol. Res."},{"issue":"7","key":"10.1016\/j.semcdb.2021.04.001_bib65","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/2162402X.2018.1448330","article-title":"Leukemia cell-derived microvesicles induce T cell exhaustion via miRNA delivery","volume":"7","author":"Cui","year":"2018","journal-title":"Oncoimmunology"},{"issue":"1","key":"10.1016\/j.semcdb.2021.04.001_bib66","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40425-019-0691-0","article-title":"MiR-448 targets IDO1 and regulates CD8+ T cell response in human colon cancer","volume":"7","author":"Lou","year":"2019","journal-title":"J. Immunother. Cancer"},{"issue":"1","key":"10.1016\/j.semcdb.2021.04.001_bib67","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13045-018-0644-y","article-title":"Targeting the IDO1 pathway in cancer: from bench to bedside","volume":"11","author":"Liu","year":"2018","journal-title":"J. Hematol. Oncol."},{"issue":"1","key":"10.1016\/j.semcdb.2021.04.001_bib68","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s13045-018-0600-x","article-title":"MiR-153 suppresses IDO1 expression and enhances CAR T cell immunotherapy","volume":"11","author":"Huang","year":"2018","journal-title":"J. Hematol. Oncol."},{"issue":"6","key":"10.1016\/j.semcdb.2021.04.001_bib69","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1158\/1541-7786.MCR-18-0831","article-title":"MiRNA-148a-3p regulates immunosuppression in DNA mismatch repair-deficient colorectal cancer by targeting PD-L1","volume":"17","author":"Ashizawa","year":"2019","journal-title":"Mol. Cancer Res."},{"issue":"Suppl 1","key":"10.1016\/j.semcdb.2021.04.001_bib70","doi-asserted-by":"crossref","first-page":"S83","DOI":"10.1517\/14712598.2013.799130","article-title":"Immunologic microenvironment and personalized treatment in multiple myeloma","volume":"13","author":"Rossi","year":"2013","journal-title":"Expert Opin. Biol. Ther."},{"issue":"2","key":"10.1016\/j.semcdb.2021.04.001_bib71","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1007\/s10753-014-9980-4","article-title":"The alteration and clinical significance of Th1\/Th2\/Th17\/Treg cells in patients with multiple myeloma","volume":"38","author":"Feng","year":"2015","journal-title":"Inflammation"},{"issue":"12","key":"10.1016\/j.semcdb.2021.04.001_bib72","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0114647","article-title":"IL-17\/miR-192\/IL-17Rs regulatory feedback loop facilitates multiple myeloma progression","volume":"9","author":"Sun","year":"2014","journal-title":"PLoS One"},{"issue":"20","key":"10.1016\/j.semcdb.2021.04.001_bib73","doi-asserted-by":"crossref","first-page":"E1248","DOI":"10.1073\/pnas.1114325109","article-title":"MicroRNA-301a regulation of a T-helper 17 immune response controls autoimmune demyelination","volume":"109","author":"Mycko","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"12","key":"10.1016\/j.semcdb.2021.04.001_bib74","doi-asserted-by":"crossref","first-page":"5599","DOI":"10.4049\/jimmunol.1303488","article-title":"miR-20b suppresses Th17 differentiation and the pathogenesis of experimental autoimmune encephalomyelitis by targeting ROR\u03b3t and STAT3","volume":"192","author":"Zhu","year":"2014","journal-title":"J. Immunol."},{"issue":"3","key":"10.1016\/j.semcdb.2021.04.001_bib75","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1002\/path.4781","article-title":"Exosomal miR-24-3p impedes T-cell function by targeting FGF11 and serves as a potential prognostic biomarker for nasopharyngeal carcinoma","volume":"240","author":"Ye","year":"2016","journal-title":"J. Pathol."},{"issue":"11","key":"10.1016\/j.semcdb.2021.04.001_bib76","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1111\/jcmm.12353","article-title":"Decreased expression of microRNA-21 correlates with the imbalance of Th17 and Treg cells in patients with rheumatoid arthritis","volume":"18","author":"Dong","year":"2014","journal-title":"J. Cell. Mol. Med."},{"issue":"2","key":"10.1016\/j.semcdb.2021.04.001_bib77","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/gene.2013.69","article-title":"Comprehensive analysis of miRNA expression in T-cell subsets of rheumatoid arthritis patients reveals defined signatures of naive and memory Tregs","volume":"15","author":"Smigielska-Czepiel","year":"2014","journal-title":"Genes Immun."},{"issue":"1","key":"10.1016\/j.semcdb.2021.04.001_bib78","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1007\/s12017-014-8335-5","article-title":"miR26a modulates Th17\/Treg balance in the EAE model of multiple sclerosis by targeting IL6","volume":"17","author":"Zhang","year":"2015","journal-title":"NeuroMolecular Med."},{"issue":"10","key":"10.1016\/j.semcdb.2021.04.001_bib79","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1038\/cr.2014.121","article-title":"Tumor-secreted miR-214 induces regulatory T cells: a major link between immune evasion and tumor growth","volume":"24","author":"Yin","year":"2014","journal-title":"Cell Res"},{"key":"10.1016\/j.semcdb.2021.04.001_bib80","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1111\/jcmm.12003","article-title":"MicroRNA-126 regulates the induction and function of CD4+ Foxp3+ regulatory T cells through PI3K\/AKT pathway","volume":"17","author":"Qin","year":"2013","journal-title":"J. Cell. Mol. Med."},{"issue":"9","key":"10.1016\/j.semcdb.2021.04.001_bib81","doi-asserted-by":"crossref","first-page":"2690","DOI":"10.3390\/jcm9092690","article-title":"Identification of microRNAs targeting the transporter associated with antigen processing TAP1 in Melanoma","volume":"9","author":"Lazaridou","year":"2020","journal-title":"J. Clin. Med."},{"issue":"3","key":"10.1016\/j.semcdb.2021.04.001_bib82","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0033395","article-title":"MiRNA-mediated control of HLA-G expression and function","volume":"7","author":"Manaster","year":"2012","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.semcdb.2021.04.001_bib83","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.rbmo.2012.06.022","article-title":"Evidence that miR-133a causes recurrent spontaneous abortion by reducing HLA-G expression","volume":"25","author":"Wang","year":"2012","journal-title":"Reprod. Biomed. Online"},{"issue":"3","key":"10.1016\/j.semcdb.2021.04.001_bib84","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/j.bbrc.2012.12.097","article-title":"MiR-9 modulates the expression of interferon-regulated genes and MHC class I molecules in human nasopharyngeal carcinoma cells","volume":"431","author":"Gao","year":"2013","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"3","key":"10.1016\/j.semcdb.2021.04.001_bib85","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/nri2506","article-title":"Myeloid-derived suppressor cells as regulators of the immune system","volume":"9","author":"Gabrilovich","year":"2009","journal-title":"Nat. Rev. Immunol."},{"issue":"3","key":"10.1016\/j.semcdb.2021.04.001_bib86","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.4049\/jimmunol.1301309","article-title":"MicroRNA-155 and MicroRNA-21 promote the expansion of functional myeloid-derived suppressor cells","volume":"192","author":"Li","year":"2014","journal-title":"J. Immunol."},{"issue":"8","key":"10.1016\/j.semcdb.2021.04.001_bib87","doi-asserted-by":"crossref","first-page":"4716","DOI":"10.4049\/jimmunol.1002989","article-title":"Both miR-17-5p and miR-20a alleviate suppressive potential of myeloid-derived suppressor cells by modulating STAT3 expression","volume":"186","author":"Zhang","year":"2011","journal-title":"J. Immunol."},{"issue":"11","key":"10.1016\/j.semcdb.2021.04.001_bib88","doi-asserted-by":"crossref","first-page":"2662","DOI":"10.1002\/ijc.25921","article-title":"MiR-223 suppresses differentiation of tumor-induced CD11b +Gr1 +myeloid-derived suppressor cells from bone marrow cells","volume":"129","author":"Liu","year":"2011","journal-title":"Int. J. Cancer"},{"issue":"11","key":"10.1016\/j.semcdb.2021.04.001_bib89","doi-asserted-by":"crossref","first-page":"5500","DOI":"10.4049\/jimmunol.1103505","article-title":"MicroRNA-494 is required for the accumulation and functions of tumor-expanded myeloid-derived suppressor cells via targeting of PTEN","volume":"188","author":"Liu","year":"2012","journal-title":"J. Immunol."},{"issue":"12","key":"10.1016\/j.semcdb.2021.04.001_bib90","doi-asserted-by":"crossref","first-page":"2868","DOI":"10.1002\/ijc.28945","article-title":"Lung tumours reprogram pulmonary Dendritic cell immunogenicity at the microrna level","volume":"135","author":"Pyfferoen","year":"2014","journal-title":"Int. J. Cancer"},{"issue":"3","key":"10.1016\/j.semcdb.2021.04.001_bib91","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0121510","article-title":"MicroRNA-22 impairs anti-tumor ability of dendritic cells by targeting p38","volume":"10","author":"Liang","year":"2015","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.semcdb.2021.04.001_bib92","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.immuni.2013.08.035","article-title":"The intracellular sensor NOD2 induces microrna-29 expression in human dendritic cells to limit IL-23 release","volume":"39","author":"Brain","year":"2013","journal-title":"Immunity"},{"issue":"9","key":"10.1016\/j.semcdb.2021.04.001_bib93","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1089\/jir.2014.0211","article-title":"IFN-\u03b1-induced downregulation of miR-221 in dendritic cells: implications for HCV pathogenesis and treatment","volume":"35","author":"Sehgal","year":"2015","journal-title":"J. Interf. Cytokine Res."},{"issue":"6","key":"10.1016\/j.semcdb.2021.04.001_bib94","doi-asserted-by":"crossref","first-page":"4657","DOI":"10.3892\/ol.2017.6048","article-title":"IL-6 and TNF-\u03b1 promote metastasis of lung cancer by inducing epithelial-mesenchymal transition","volume":"13","author":"Shang","year":"2017","journal-title":"Oncol. Lett."},{"issue":"4","key":"10.1016\/j.semcdb.2021.04.001_bib95","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1038\/leu.2017.336","article-title":"MIR-29b antagonizes the pro-inflammatory tumor-promoting activity of multiple myeloma-educated dendritic cells","volume":"32","author":"Botta","year":"2018","journal-title":"Leukemia"},{"issue":"8","key":"10.1016\/j.semcdb.2021.04.001_bib96","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1038\/gene.2012.45","article-title":"TGF-\u03b2-associated miR-27a inhibits dendritic cell-mediated differentiation of Th1 and Th17 cells by TAB3, p38 MAPK, MAP2K4 and MAP2K7","volume":"13","author":"Min","year":"2012","journal-title":"Genes Immun."},{"issue":"6","key":"10.1016\/j.semcdb.2021.04.001_bib97","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1007\/s00262-020-02507-w","article-title":"miRNA-5119 regulates immune checkpoints in dendritic cells to enhance breast cancer immunotherapy","volume":"69","author":"Zhang","year":"2020","journal-title":"Cancer Immunol. Immunother."},{"issue":"1","key":"10.1016\/j.semcdb.2021.04.001_bib98","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2020.1724761","article-title":"Overexpression of microRNA-155 enhances the efficacy of dendritic cell vaccine against breast cancer","volume":"9","author":"Hodge","year":"2020","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.semcdb.2021.04.001_bib99","doi-asserted-by":"crossref","first-page":"5275","DOI":"10.1038\/ncomms6275","article-title":"Lysophospholipids secreted by splenic macrophages induce chemotherapy resistance via interference with the DNA damage response","volume":"5","author":"Houthuijzen","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.semcdb.2021.04.001_bib100","doi-asserted-by":"crossref","first-page":"4586","DOI":"10.1158\/0008-5472.CAN-17-3841","article-title":"Hypoxic tumor-derived exosomal miR-301a mediates M2 macrophage polarization via PTEN\/PI3Kg to promote pancreatic cancer metastasis","volume":"78","author":"Wang","year":"2018","journal-title":"Cancer Res."},{"key":"10.1016\/j.semcdb.2021.04.001_bib101","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.ymthe.2017.11.016","article-title":"Hypoxic lung-cancer-derived extracellular vesicle MicroRNA-103a increases the oncogenic effects of macrophages by targeting PTEN","volume":"26","author":"Hsu","year":"2018","journal-title":"Mol. Ther."},{"key":"10.1016\/j.semcdb.2021.04.001_bib102","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1158\/2326-6066.CIR-17-0479","article-title":"Exosomes released from tumor-associated macrophages transfer miRNAs that induce a Treg\/Th17 cell imbalance in epithelial ovarian cancer","volume":"6","author":"Zhou","year":"2018","journal-title":"Cancer Immunol. Res."},{"issue":"1","key":"10.1016\/j.semcdb.2021.04.001_bib103","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1158\/0008-5472.CAN-18-0014","article-title":"M2 macrophage-derived exosomes promote cell migration and invasion in colon cancer","volume":"79","author":"Lan","year":"2019","journal-title":"Cancer Res."},{"issue":"11","key":"10.1016\/j.semcdb.2021.04.001_bib104","doi-asserted-by":"crossref","first-page":"2746","DOI":"10.1002\/ijc.31988","article-title":"Circulating mir-320a promotes immunosuppressive macrophages M2 phenotype associated with lung cancer risk","volume":"144","author":"Fortunato","year":"2019","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.semcdb.2021.04.001_bib105","doi-asserted-by":"crossref","first-page":"2368","DOI":"10.1111\/cas.14110","article-title":"Hypoxia decreases macrophage glycolysis and M1 percentage by targeting microRNA-30c and mTOR in human gastric cancer","volume":"110","author":"Zhihua","year":"2019","journal-title":"Cancer Sci."},{"issue":"1","key":"10.1016\/j.semcdb.2021.04.001_bib106","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13046-019-1313-x","article-title":"Macrophage-derived exosomal microRNA-501-3p promotes progression of pancreatic ductal adenocarcinoma through the TGFBR3-mediated TGF-\u03b2 signaling pathway","volume":"38","author":"Yin","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"31","key":"10.1016\/j.semcdb.2021.04.001_bib107","doi-asserted-by":"crossref","first-page":"E2110","DOI":"10.1073\/pnas.1209414109","article-title":"MicroRNAs bind to Toll-like receptors to induce prometastatic inflammatory response","volume":"109","author":"Fabbri","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"5","key":"10.1016\/j.semcdb.2021.04.001_bib108","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1002\/hep.28445","article-title":"miR-28-5p-IL-34-macrophage feedback loop modulates hepatocellular carcinoma metastasis","volume":"63","author":"Zhou","year":"2016","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.semcdb.2021.04.001_bib109","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1038\/s41467-019-08989-2","article-title":"Apoptotic tumor cell-derived microRNA-375 uses CD36 to alter the tumor-associated macrophage phenotype","volume":"10","author":"Frank","year":"2019","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.semcdb.2021.04.001_bib110","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.celrep.2011.12.005","article-title":"MiR-511-3p modulates genetic programs of tumor-associated macrophages","volume":"1","author":"Squadrito","year":"2012","journal-title":"Cell Rep."},{"issue":"16","key":"10.1016\/j.semcdb.2021.04.001_bib111","doi-asserted-by":"crossref","first-page":"4779","DOI":"10.7150\/thno.32543","article-title":"The miR-561-5p\/CX3CL1 signaling axis regulates pulmonary metastasis in hepatocellular carcinoma involving CX3CR1+ natural killer cells infiltration","volume":"9","author":"Chen","year":"2019","journal-title":"Theranostics"},{"key":"10.1016\/j.semcdb.2021.04.001_bib112","doi-asserted-by":"crossref","first-page":"2360","DOI":"10.3389\/fimmu.2018.02360","article-title":"New miRNA signature heralds human NK cell subsets at different maturation steps: involvement of miR-146a-5p in the regulation of KIR expression","volume":"9","author":"Pesce","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.semcdb.2021.04.001_bib113","first-page":"603","article-title":"Regulation of KIR3DL3 expression via mirna","volume":"10","author":"Nutalai","year":"2019"},{"issue":"2","key":"10.1016\/j.semcdb.2021.04.001_bib114","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1002\/eji.201747128","article-title":"KIR downregulation by IL-12\/15\/18 unleashes human NK cells from KIR\/HLA-I inhibition and enhances killing of tumor cells","volume":"48","author":"Ewen","year":"2018","journal-title":"Eur. J. Immunol."},{"issue":"4","key":"10.1016\/j.semcdb.2021.04.001_bib115","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2018.1557372","article-title":"Immune evasion by TGF\u03b2-induced miR-183 repression of MICA\/B expression in human lung tumor cells","volume":"8","author":"Le Trinh","year":"2019","journal-title":"Oncoimmunology"},{"issue":"5","key":"10.1016\/j.semcdb.2021.04.001_bib116","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/cmi.2014.30","article-title":"Ovarian tumor-associated microRNA-20a decreases natural killer cell cytotoxicity by downregulating MICA\/B expression","volume":"11","author":"Xie","year":"2014","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.semcdb.2021.04.001_bib117","doi-asserted-by":"crossref","first-page":"2739","DOI":"10.1038\/srep02739","article-title":"Regulation of the expression of the liver cancer susceptibility gene MICA by microRNAs","volume":"3","author":"Kishikawa","year":"2013","journal-title":"Sci. Rep."},{"issue":"9","key":"10.1016\/j.semcdb.2021.04.001_bib118","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.3324\/haematol.2011.058529","article-title":"Human microRNA-1245 down-regulates the NKG2D receptor in natural killer cells and impairs NKG2D-mediated functions","volume":"97","author":"Luis Espinoza","year":"2012","journal-title":"Haematologica"},{"issue":"21","key":"10.1016\/j.semcdb.2021.04.001_bib119","doi-asserted-by":"crossref","first-page":"5463","DOI":"10.1158\/0008-5472.CAN-11-2671","article-title":"MiR-10b downregulates the stress-induced cell surface molecule MICB, a critical ligand for cancer cell recognition by natural killer cells","volume":"72","author":"Tsukerman","year":"2012","journal-title":"Cancer Res."},{"issue":"17","key":"10.1016\/j.semcdb.2021.04.001_bib120","doi-asserted-by":"crossref","first-page":"7651","DOI":"10.18632\/oncotarget.2287","article-title":"MicroRNA-mediated down-regulation of NKG2D ligands contributes to glioma immune escape","volume":"5","author":"Codo","year":"2014","journal-title":"Oncotarget"},{"issue":"6","key":"10.1016\/j.semcdb.2021.04.001_bib121","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2015.1008805","article-title":"Clinical relevance of miR-mediated HLA-G regulation and the associated immune cell infiltration in renal cell carcinoma","volume":"4","author":"Jasinski-Bergner","year":"2015","journal-title":"Oncoimmunology"},{"issue":"4","key":"10.1016\/j.semcdb.2021.04.001_bib122","first-page":"4797","article-title":"MicroRNA-374b inhibits liver cancer progression via down regulating programmed cell death-1 expression on cytokine-induced killer cells","volume":"15","author":"Huang","year":"2018","journal-title":"Oncol. Lett."},{"issue":"6","key":"10.1016\/j.semcdb.2021.04.001_bib123","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1158\/0008-5472.CAN-18-0779","article-title":"Natural killer\u2013derived exosomal miR-186 inhibits neuroblastoma growth and immune escape mechanisms","volume":"79","author":"Neviani","year":"2019","journal-title":"Cancer Res."},{"issue":"30","key":"10.1016\/j.semcdb.2021.04.001_bib124","doi-asserted-by":"crossref","first-page":"4016","DOI":"10.1038\/onc.2013.387","article-title":"Tumor resident mesenchymal stromal cells endow na\u00efve stromal cells with tumor-promoting properties","volume":"33","author":"Ren","year":"2014","journal-title":"Oncogene"},{"issue":"8","key":"10.1016\/j.semcdb.2021.04.001_bib125","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0071637","article-title":"Loss of let-7 microRNA upregulates IL-6 in bone marrow-derived mesenchymal stem cells triggering a reactive stromal response to prostate cancer","volume":"8","author":"Sung","year":"2013","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.semcdb.2021.04.001_bib126","doi-asserted-by":"crossref","first-page":"437","DOI":"10.3324\/haematol.2015.134932","article-title":"Extracellular vesicle miR-7977 is involved in hematopoietic dysfunction of mesenchymal stromal cells via poly(rC) binding protein 1 reduction in myeloid neoplasms","volume":"101","author":"Horiguchi","year":"2016","journal-title":"Haematologica"},{"issue":"1","key":"10.1016\/j.semcdb.2021.04.001_bib127","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s13046-019-1027-0","article-title":"Extracellular vesicles secreted by hypoxia pre-challenged mesenchymal stem cells promote non-small cell lung cancer cell growth and mobility as well as macrophage M2 polarization via miR-21-5p delivery","volume":"38","author":"Ren","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.semcdb.2021.04.001_bib128","doi-asserted-by":"crossref","first-page":"7728","DOI":"10.1002\/cam4.2633","article-title":"Exosomal miRNA-1231 derived from bone marrow mesenchymal stem cells inhibits the activity of pancreatic cancer","volume":"8","author":"Shang","year":"2019","journal-title":"Cancer Med."},{"issue":"1","key":"10.1016\/j.semcdb.2021.04.001_bib129","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s12951-019-0563-2","article-title":"Engineered exosomes for targeted co-delivery of miR-21 inhibitor and chemotherapeutics to reverse drug resistance in colon cancer","volume":"18","author":"Liang","year":"2020","journal-title":"J. Nanobiotechnology"},{"issue":"1","key":"10.1016\/j.semcdb.2021.04.001_bib130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13046-019-1488-1","article-title":"Human bone marrow mesenchymal stem cells-derived microRNA-205-containing exosomes impede the progression of prostate cancer through suppression of RHPN2","volume":"38","author":"Jiang","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"16","key":"10.1016\/j.semcdb.2021.04.001_bib131","doi-asserted-by":"crossref","first-page":"5140","DOI":"10.1158\/0008-5472.CAN-13-1168-T","article-title":"RHPN2 drives mesenchymal transformation in malignant glioma by triggering RhoA activation","volume":"73","author":"Danussi","year":"2013","journal-title":"Cancer Res."},{"issue":"1\u20132","key":"10.1016\/j.semcdb.2021.04.001_bib132","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s11010-019-03526-7","article-title":"Exosomes derived from microRNA-101-3p-overexpressing human bone marrow mesenchymal stem cells suppress oral cancer cell proliferation, invasion, and migration","volume":"458","author":"Xie","year":"2019","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.semcdb.2021.04.001_bib133","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.omtn.2019.02.022","article-title":"Bone marrow mesenchymal stem cell-derived exosomal MicroRNA-126-3p inhibits pancreatic cancer development by targeting ADAM9","volume":"16","author":"Wu","year":"2019","journal-title":"Mol. Ther. Nucleic Acids"},{"issue":"13","key":"10.1016\/j.semcdb.2021.04.001_bib134","doi-asserted-by":"crossref","first-page":"16567","DOI":"10.18632\/oncotarget.7767","article-title":"miR-155-5p inhibition promotes the transition of bone marrow mesenchymal stem cells to gastric cancer tissue derived MSC-like cells via NF-\u03baB p65 activation","volume":"7","author":"Zhu","year":"2016","journal-title":"Oncotarget"},{"issue":"5","key":"10.1016\/j.semcdb.2021.04.001_bib135","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1038\/bjc.2014.14","article-title":"Deregulated microRNAs in gastric cancer tissue-derived mesenchymal stem cells: Novel biomarkers and a mechanism for gastric cancer","volume":"110","author":"Wang","year":"2014","journal-title":"Br. J. Cancer"},{"issue":"1","key":"10.1016\/j.semcdb.2021.04.001_bib136","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13046-020-01631-w","article-title":"Human umbilical cord mesenchymal stem cells-derived exosomes deliver microRNA-375 to downregulate ENAH and thus retard esophageal squamous cell carcinoma progression","volume":"39","author":"He","year":"2020","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.semcdb.2021.04.001_bib137","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fonc.2019.01076","article-title":"Exosomes derived from microrna-148b-3p-overexpressing human umbilical cord mesenchymal stem cells restrain breast cancer progression","volume":"9","author":"Yuan","year":"2019","journal-title":"Front. Oncol."},{"issue":"1","key":"10.1016\/j.semcdb.2021.04.001_bib138","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13046-019-1512-5","article-title":"MiR-199a-modified exosomes from adipose tissue-derived mesenchymal stem cells improve hepatocellular carcinoma chemosensitivity through mTOR pathway","volume":"39","author":"Lou","year":"2020","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"6","key":"10.1016\/j.semcdb.2021.04.001_bib139","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/j.stem.2014.10.001","article-title":"MSC-regulated microRNAs converge on the transcription factor FOXP2 and promote breast cancer metastasis","volume":"15","author":"Cuiffo","year":"2014","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.semcdb.2021.04.001_bib140","doi-asserted-by":"crossref","first-page":"5300","DOI":"10.18632\/aging.102092","article-title":"Exosomes derived from microRNA-199a-overexpressing mesenchymal stem cells inhibit glioma progression by down-regulating AGAP2","volume":"11","author":"Yu","year":"2019","journal-title":"Aging (Albany NY)"},{"issue":"9","key":"10.1016\/j.semcdb.2021.04.001_bib141","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1038\/ncb3399","article-title":"Melanoma miRNA trafficking controls tumour primary niche formation","volume":"18","author":"Dror","year":"2016","journal-title":"Nat. Cell Biol."},{"issue":"16","key":"10.1016\/j.semcdb.2021.04.001_bib142","doi-asserted-by":"crossref","first-page":"3972","DOI":"10.7150\/thno.18990","article-title":"MiR-205\/YAP1 in activated fibroblasts of breast tumor promotes VEGF-independent angiogenesis through STAT3 signaling","volume":"7","author":"Du","year":"2017","journal-title":"Theranostics"},{"issue":"1","key":"10.1016\/j.semcdb.2021.04.001_bib143","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1038\/cdd.2015.78","article-title":"Stromal miR-200s contribute to breast cancer cell invasion through CAF activation and ECM remodeling","volume":"23","author":"Tang","year":"2016","journal-title":"Cell Death Differ."},{"issue":"3","key":"10.1016\/j.semcdb.2021.04.001_bib144","doi-asserted-by":"crossref","first-page":"2943","DOI":"10.1002\/jcp.27111","article-title":"Loss of exosomal miR-148b from cancer-associated fibroblasts promotes endometrial cancer cell invasion and cancer metastasis","volume":"234","author":"Li","year":"2019","journal-title":"J. Cell. Physiol."},{"issue":"10","key":"10.1016\/j.semcdb.2021.04.001_bib145","doi-asserted-by":"crossref","first-page":"2466","DOI":"10.1016\/j.ymthe.2018.07.023","article-title":"Exosome-derived miR-130a activates angiogenesis in gastric cancer by targeting C-MYB in vascular endothelial cells","volume":"26","author":"Yang","year":"2018","journal-title":"Mol. Ther."},{"key":"10.1016\/j.semcdb.2021.04.001_bib146","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.omto.2019.10.006","article-title":"Exosomes carrying MicroRNA-155 target forkhead box O3 of endothelial cells and promote angiogenesis in gastric cancer","volume":"15","author":"Zhou","year":"2019","journal-title":"Mol. Ther. Oncolytics."},{"issue":"2","key":"10.1016\/j.semcdb.2021.04.001_bib147","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s12079-020-00548-5","article-title":"microRNA-141-3p-containing small extracellular vesicles derived from epithelial ovarian cancer cells promote endothelial cell angiogenesis through activating the JAK\/STAT3 and NF-\u03baB signaling pathways","volume":"14","author":"Masoumi-Dehghi","year":"2020","journal-title":"J. Cell Commun. Signal."},{"key":"10.1016\/j.semcdb.2021.04.001_bib148","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fgene.2019.01397","article-title":"MiR-199b-5p suppresses tumor angiogenesis mediated by vascular endothelial cells in breast cancer by targeting ALK1","volume":"10","author":"Lin","year":"2020","journal-title":"Front. Genet."},{"key":"10.1016\/j.semcdb.2021.04.001_bib149","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2019.117162","article-title":"MiR-21 modulates the polarization of macrophages and increases the effects of M2 macrophages on promoting the chemoresistance of ovarian cancer","volume":"242","author":"An","year":"2020","journal-title":"Life Sci."},{"issue":"1","key":"10.1016\/j.semcdb.2021.04.001_bib150","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13046-017-0528-y","article-title":"Exosomal transfer of tumor-associated macrophage-derived miR-21 confers cisplatin resistance in gastric cancer cells","volume":"36","author":"Zheng","year":"2017","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.semcdb.2021.04.001_bib151","first-page":"1","article-title":"Upregulated MELK leads to doxorubicin chemoresistance and M2 macrophage polarization via the miR-34a\/JAK2\/STAT3 pathway in uterine leiomyosarcoma","volume":"10","author":"Zhang","year":"2020","journal-title":"Front. Oncol."},{"issue":"23","key":"10.1016\/j.semcdb.2021.04.001_bib152","doi-asserted-by":"crossref","first-page":"7375","DOI":"10.1158\/1078-0432.CCR-17-1283","article-title":"The immune-microenvironment confers chemoresistance of colorectal cancer through macrophage-derived IL6","volume":"23","author":"Yin","year":"2017","journal-title":"Clin. Cancer Res."},{"issue":"10","key":"10.1016\/j.semcdb.2021.04.001_bib153","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1016\/j.molonc.2016.08.005","article-title":"Autophagy inhibition upregulates CD4+ tumor infiltrating lymphocyte expression via miR-155 regulation and TRAIL activation","volume":"10","author":"Zarogoulidis","year":"2016","journal-title":"Mol. Oncol."},{"issue":"29","key":"10.1016\/j.semcdb.2021.04.001_bib154","doi-asserted-by":"crossref","first-page":"3812","DOI":"10.1038\/onc.2013.357","article-title":"Macrophages mediate gemcitabine resistance of pancreatic adenocarcinoma by upregulating cytidine deaminase","volume":"33","author":"Weizman","year":"2014","journal-title":"Oncogene"},{"issue":"18","key":"10.1016\/j.semcdb.2021.04.001_bib155","doi-asserted-by":"crossref","first-page":"5287","DOI":"10.1158\/0008-5472.CAN-18-0124","article-title":"Transfer of miRNA in macrophage-derived exosomes induces drug resistance in pancreatic adenocarcinoma","volume":"78","author":"Binenbaum","year":"2018","journal-title":"Cancer Res."},{"key":"10.1016\/j.semcdb.2021.04.001_bib156","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.ebiom.2018.11.004","article-title":"Exosomal miRNA confers chemo resistance via targeting Cav1\/p-gp\/M2-type macrophage axis in ovarian cancer","volume":"38","author":"Kanlikilicer","year":"2018","journal-title":"EBioMedicine"},{"key":"10.1016\/j.semcdb.2021.04.001_bib157","doi-asserted-by":"crossref","first-page":"5994","DOI":"10.1111\/jcmm.14462","article-title":"Metformin mediates induction of miR-708 to inhibit self-renewal and chemoresistance of breast cancer stem cells through targeting CD47","volume":"23","author":"Tan","year":"2019","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.semcdb.2021.04.001_bib158","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13046-019-1095-1","article-title":"Macrophages derived exosomes deliver miR-223 to epithelial ovarian cancer cells to elicit a chemoresistant phenotype","volume":"38","author":"Zhu","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"5","key":"10.1016\/j.semcdb.2021.04.001_bib159","first-page":"824","article-title":"Natural killer cells inhibit oxaliplatin-resistant colorectal cancer by repressing WBSCR22 via upregulating microRNA-146b-5p","volume":"8","author":"Zhao","year":"2018","journal-title":"Am. J. Cancer Res."},{"issue":"4","key":"10.1016\/j.semcdb.2021.04.001_bib160","first-page":"1164","article-title":"The bone marrow microenvironment as a mediator of chemoresistance in acute lymphoblastic leukemia","volume":"2","author":"Meyer","year":"2019","journal-title":"Cancer Drug Resist."},{"issue":"11","key":"10.1016\/j.semcdb.2021.04.001_bib161","doi-asserted-by":"crossref","first-page":"14565","DOI":"10.1007\/s13277-016-5289-2","article-title":"Role of miRNA dynamics and cytokine profile in governing CD44v6\/Nanog\/PTEN axis in oral cancer: modulating the master regulators","volume":"37","author":"Patel","year":"2016","journal-title":"Tumor Biol."},{"issue":"18","key":"10.1016\/j.semcdb.2021.04.001_bib162","doi-asserted-by":"crossref","first-page":"5144","DOI":"10.1158\/1078-0432.CCR-12-0701","article-title":"Let-7 expression is a significant determinant of response to chemotherapy through the regulation of IL-6\/STAT3 pathway in esophageal squamous cell carcinoma","volume":"18","author":"Sugimura","year":"2012","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.semcdb.2021.04.001_bib163","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/ncomms2393","article-title":"MicroRNA-30c inhibits human breast tumour chemotherapy resistance by regulating TWF1 and IL-11","volume":"4","author":"Bockhorn","year":"2013","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.semcdb.2021.04.001_bib164","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13045-015-0220-7","article-title":"Exosomes derived from MIR-122-modified adipose tissue-derived MSCs increase chemosensitivity of hepatocellular carcinoma","volume":"8","author":"Lou","year":"2015","journal-title":"J. Hematol. Oncol."},{"issue":"21","key":"10.1016\/j.semcdb.2021.04.001_bib165","doi-asserted-by":"crossref","first-page":"18389","DOI":"10.18632\/oncotarget.4089","article-title":"MiR-101 targets DUSP1 to regulate the TGF-\u03b2 secretion in sorafenib inhibits macrophage-induced growth of hepatocarcinoma","volume":"6","author":"Wei","year":"2015","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.semcdb.2021.04.001_bib166","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13046-020-01648-1","article-title":"Circular RNA circ-CPA4\/ let-7 miRNA\/PD-L1 axis regulates cell growth, stemness, drug resistance and immune evasion in non-small cell lung cancer (NSCLC)","volume":"39","author":"Hong","year":"2020","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"12","key":"10.1016\/j.semcdb.2021.04.001_bib167","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41419-020-03224-z","article-title":"Anti-PD1 therapy induces lymphocyte-derived exosomal miRNA-4315 release inhibiting Bim-mediated apoptosis of tumor cells","volume":"11","author":"Guyon","year":"2020","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.semcdb.2021.04.001_bib168","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2020\/8029721","article-title":"Development of microRNAs as potential therapeutics against cancer","volume":"2020","author":"Abd-Aziz","year":"2020","journal-title":"J. Oncol."},{"key":"10.1016\/j.semcdb.2021.04.001_bib169","doi-asserted-by":"crossref","DOI":"10.5772\/intechopen.81847","article-title":"MiRNA-based therapeutics in oncology, realities, and challenges","author":"Balacescu","year":"2019","journal-title":"Antisense Ther. IntechOpen"},{"key":"10.1016\/j.semcdb.2021.04.001_bib170","article-title":"Progress and promises of epigenetic drugs and epigenetic diets in cancer prevention and therapy: a clinical update","author":"Mondal","year":"2020","journal-title":"Semin. Cancer Biol."},{"issue":"1","key":"10.1016\/j.semcdb.2021.04.001_bib171","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s40139-012-0004-5","article-title":"miRNA-based therapeutic strategies","volume":"1","author":"Ishida","year":"2013","journal-title":"Curr. Pathobiol. Rep."},{"issue":"2","key":"10.1016\/j.semcdb.2021.04.001_bib172","first-page":"114","article-title":"How close are miRNAs from clinical practice? A perspective on the diagnostic and therapeutic market","volume":"30","author":"Bonneau","year":"2019","journal-title":"Electron. J. Int. Fed. Clin. Chem. Lab. Med."},{"issue":"9","key":"10.1016\/j.semcdb.2021.04.001_bib173","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1080\/17460441.2020.1765770","article-title":"Challenges identifying efficacious miRNA therapeutics for cancer","volume":"15","author":"Segal","year":"2020","journal-title":"Expert Opin. Drug Discov."},{"issue":"17","key":"10.1016\/j.semcdb.2021.04.001_bib174","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.4155\/fmc.14.116","article-title":"MiRNA-based therapies: strategies and delivery platforms for oligonucleotide and non-oligonucleotide agents","volume":"6","author":"Baumann","year":"2014","journal-title":"Future Med. Chem."},{"issue":"1","key":"10.1016\/j.semcdb.2021.04.001_bib175","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s41544-019-0024-y","article-title":"Recent progress in microRNA-based delivery systems for the treatment of human disease","volume":"1","author":"Fu","year":"2019","journal-title":"ExRNA"},{"issue":"2","key":"10.1016\/j.semcdb.2021.04.001_bib176","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1007\/s10637-016-0407-y","article-title":"Phase I study of MRX34, a liposomal miR-34a mimic, administered twice weekly in patients with advanced solid tumors","volume":"35","author":"Beg","year":"2017","journal-title":"Invest. N. Drugs"},{"issue":"11","key":"10.1016\/j.semcdb.2021.04.001_bib177","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1038\/s41416-020-0802-1","article-title":"Phase 1 study of MRX34, a liposomal miR-34a mimic, in patients with advanced solid tumours","volume":"122","author":"Hong","year":"2020","journal-title":"Br. J. Cancer"},{"issue":"10","key":"10.1016\/j.semcdb.2021.04.001_bib178","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1016\/S1470-2045(17)30621-6","article-title":"Safety and activity of microRNA-loaded minicells in patients with recurrent malignant pleural mesothelioma: a first-in-man, phase 1, open-label, dose-escalation study","volume":"18","author":"van Zandwijk","year":"2017","journal-title":"Lancet Oncol."},{"issue":"8","key":"10.1016\/j.semcdb.2021.04.001_bib179","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.2217\/epi-2016-0035","article-title":"Clinical development of TargomiRs, a miRNA mimic-based treatment for patients with recurrent thoracic cancer","volume":"8","author":"Reid","year":"2016","journal-title":"Epigenomics"},{"key":"10.1016\/j.semcdb.2021.04.001_bib180","doi-asserted-by":"crossref","first-page":"32","DOI":"10.3390\/cancers10020032","article-title":"Tackling cancer resistance by immunotherapy: updated clinical impact and safety of PD-1\/PD-L1 inhibitors","author":"Abdin","year":"2018","journal-title":"Cancers (Basel)"},{"issue":"3","key":"10.1016\/j.semcdb.2021.04.001_bib181","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.ncrna.2019.10.001","article-title":"Non-coding RNAs, a real next-gen class of biomarkers?","volume":"4","author":"Borga","year":"2019","journal-title":"Non Coding RNA Res."},{"key":"10.1016\/j.semcdb.2021.04.001_bib182","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1007\/s10529-017-2397-z","article-title":"miR-34a attenuates glioma cells progression and chemoresistance via targeting PD-L1","volume":"39","author":"Wang","year":"2017","journal-title":"Biotechnol. Lett."},{"key":"10.1016\/j.semcdb.2021.04.001_bib183","doi-asserted-by":"crossref","first-page":"467","DOI":"10.3727\/096504020X15925659763817","article-title":"Programmed death ligand-1 (PD-L1) regulated by NRF-2\/MicroRNA-1 regulatory axis enhances drug resistance and promotes tumorigenic properties in sorafenib-resistant hepatoma cells","volume":"28","author":"Li","year":"2021","journal-title":"Oncol. Res."},{"key":"10.1016\/j.semcdb.2021.04.001_bib184","doi-asserted-by":"crossref","first-page":"3847","DOI":"10.1111\/jcmm.13657","article-title":"The miR-3127-5p\/p-STAT3 axis up-regulates PD-L1 inducing chemoresistance in non-small-cell lung cancer","volume":"22","author":"Tang","year":"2018","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.semcdb.2021.04.001_bib185","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.yexcr.2019.03.025","article-title":"miR3609 sensitizes breast cancer cells to adriamycin by blocking the programmed death-ligand 1 immune checkpoint","volume":"380","author":"Li","year":"2019","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.semcdb.2021.04.001_bib186","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1631\/jzus.B1800190","article-title":"MiR-1180 from bone marrow-derived mesenchymal stem cells induces glycolysis and chemoresistance in ovarian cancer cells by upregulating the Wnt signaling pathway","volume":"20","author":"Gu","year":"2019","journal-title":"J. Zhejiang Univ. Sci. B"},{"key":"10.1016\/j.semcdb.2021.04.001_bib187","doi-asserted-by":"crossref","first-page":"561","DOI":"10.2147\/IJN.S271976","article-title":"CAFs-derived exosomal miRNA-130a confers cisplatin resistance of NSCLC cells through PUM2-dependent packaging","volume":"16","author":"Zhang","year":"2021","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.semcdb.2021.04.001_bib188","doi-asserted-by":"crossref","first-page":"3523","DOI":"10.3892\/or.2016.4714","article-title":"Mir-1-mediated paracrine effect of cancer- associated fibroblasts on lung cancer cell proliferation and chemoresistance","volume":"35","author":"Li","year":"2016","journal-title":"Oncol. Rep."}],"container-title":["Seminars in Cell & Developmental Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1084952121000744?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1084952121000744?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T17:12:01Z","timestamp":1761066721000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1084952121000744"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":188,"alternative-id":["S1084952121000744"],"URL":"https:\/\/doi.org\/10.1016\/j.semcdb.2021.04.001","relation":{},"ISSN":["1084-9521"],"issn-type":[{"value":"1084-9521","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The emerging role of miRNA in the perturbation of tumor immune microenvironment in chemoresistance: Therapeutic implications","name":"articletitle","label":"Article Title"},{"value":"Seminars in Cell & Developmental Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semcdb.2021.04.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}